• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Keep taking your blood pressure medicine

29th March 2020 by PIP editor Leave a Comment

 

The UK Government has come out and made a statement about the recent controversy that ACE-I or ARBs may worsen COVID-19.

 

The Government has stated that there is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.

 

They have stated that if people are taking angiotensin-converting enzyme inhibitors (ACE inhibitors or ACE-i) or angiotensin receptor blockers (ARBs) to treat high blood pressure, it is vitally important that they continue their usual treatment.

 

Whilst some media reports and publications have suggested that treatment with ACE-I or ARBs might worsen COVID-19 infection, there is no evidence from clinical or epidemiological studies to support this.

 

The Government has said that they recognise the concern that the COVID-19 outbreak is causing, and have assured the public that they are working closely with the Commission on Human Medicines and other regulatory bodies to ensure we can respond with further advice on this issue, should any new data emerge.

 

The European Society of Cardiology published a position statement on ACE-Inhibitors and angiotensin receptor blockers which can be viewed by clicking here.

 

The European Medicine Agency has advised continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic and you can view their statement by clicking here.

 

The Renal Association in the UK published a position statement on COVID-19 and ACE Inhibitor/angiotensin receptor blocker use which you can view by clicking here.

 

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Safer medicines in pregnancy and breastfeeding consortium launched

Filed Under: COVID-19, News Tagged With: Coronavirus, PIP news

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Should pharmacists be sent to check home medicine cupboards?

All over the counter opiates should be made prescription only

Pharmacy technicians could help reduce medication waste

Pharmacies should be allowed to supply rapid antibody tests

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.